Nuplazid rejected for Alzheimer’s psychosis
The US FDA rejects pimavanserin / Nuplazid for Alzheimer’s psychosis.
3 Likes
Yeah i remember reading that like a few weeks ago. I guess it dosnt get rid of psychosis from alzheimer folks? Thats too bad for them.
It might be the clinical trial was not well designed. It included patients with other dementias.